Manuel Chacón-Diaz, Akram Hernández-Vásquez, Piero Custodio-Sánchez
{"title":"[秘鲁ST段抬高型心肌梗死患者的一年存活率]。","authors":"Manuel Chacón-Diaz, Akram Hernández-Vásquez, Piero Custodio-Sánchez","doi":"10.47487/apcyccv.v3i2.218","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>To determine one-year survival and factors associated with mortality in patients with ST-segment elevation myocardial infarction in Peru.</p><p><strong>Methods: </strong>An analysis was made of the cohort of patients included in the PERSTEMI-II registry during the year 2020, in whom survival at one year after the event and its risk factors were evaluated using Kaplan-Meier survival analysis and Cox regression.</p><p><strong>Results: </strong>Of 374 patients in the PERSTEMI-II study, 366 (97.9%) completed follow-up up to one year after the event with a survival rate of 85%. Successful reperfusion was related to better survival at 1 year (hazard ratio [HR]=0.30, 95% CI: 0.14-0.62, p=0.001). Age (HR=1.04, 95% CI: 1.01-1.07, p=0.003), chronic kidney disease (HR=2.15, 95% CI: 1.04-4.39, p=0.037) and cardiogenic shock (HR=6.67, 95% CI: 3.72-11.97, p<0.001) were factors of higher mortality at 1-year follow-up.</p><p><strong>Conclusion: </strong>The PERSTEMI-II registry is the first Peruvian registry that provides data on survival after ST-segment elevation myocardial infarction, which is 85% at one year. Successful reperfusion improves survival at one-year post infarction.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"3 2","pages":"53-59"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/de/apcyccv-3-53.PMC10284578.pdf","citationCount":"0","resultStr":"{\"title\":\"[One-year survival among patients with ST-elevation myocardial infarction in Peru].\",\"authors\":\"Manuel Chacón-Diaz, Akram Hernández-Vásquez, Piero Custodio-Sánchez\",\"doi\":\"10.47487/apcyccv.v3i2.218\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objectives: </strong>To determine one-year survival and factors associated with mortality in patients with ST-segment elevation myocardial infarction in Peru.</p><p><strong>Methods: </strong>An analysis was made of the cohort of patients included in the PERSTEMI-II registry during the year 2020, in whom survival at one year after the event and its risk factors were evaluated using Kaplan-Meier survival analysis and Cox regression.</p><p><strong>Results: </strong>Of 374 patients in the PERSTEMI-II study, 366 (97.9%) completed follow-up up to one year after the event with a survival rate of 85%. Successful reperfusion was related to better survival at 1 year (hazard ratio [HR]=0.30, 95% CI: 0.14-0.62, p=0.001). Age (HR=1.04, 95% CI: 1.01-1.07, p=0.003), chronic kidney disease (HR=2.15, 95% CI: 1.04-4.39, p=0.037) and cardiogenic shock (HR=6.67, 95% CI: 3.72-11.97, p<0.001) were factors of higher mortality at 1-year follow-up.</p><p><strong>Conclusion: </strong>The PERSTEMI-II registry is the first Peruvian registry that provides data on survival after ST-segment elevation myocardial infarction, which is 85% at one year. Successful reperfusion improves survival at one-year post infarction.</p>\",\"PeriodicalId\":72295,\"journal\":{\"name\":\"Archivos Peruanos de cardiologia y cirugia cardiovascular\",\"volume\":\"3 2\",\"pages\":\"53-59\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a5/de/apcyccv-3-53.PMC10284578.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archivos Peruanos de cardiologia y cirugia cardiovascular\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.47487/apcyccv.v3i2.218\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/4/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos Peruanos de cardiologia y cirugia cardiovascular","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.47487/apcyccv.v3i2.218","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/4/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
目的:确定秘鲁 ST 段抬高型心肌梗死患者的一年生存率以及与死亡率相关的因素:确定秘鲁 ST 段抬高型心肌梗死患者的一年生存率以及与死亡率相关的因素:方法:对 2020 年纳入 PERSTEMI-II 登记的患者进行分析,采用 Kaplan-Meier 生存分析和 Cox 回归对患者发病后一年的生存率及其风险因素进行评估:在PERSTEMI-II研究的374名患者中,366人(97.9%)在事件发生一年后完成了随访,存活率为85%。成功再灌注与更好的1年生存率相关(危险比[HR]=0.30,95% CI:0.14-0.62,P=0.001)。年龄(HR=1.04,95% CI:1.01-1.07,p=0.003)、慢性肾脏病(HR=2.15,95% CI:1.04-4.39,p=0.037)和心源性休克(HR=6.67,95% CI:3.72-11.97,p结论:PERSTEMI-II登记是秘鲁首个提供ST段抬高型心肌梗死后存活率数据的登记,一年后存活率为85%。成功的再灌注提高了心梗后一年的存活率。
[One-year survival among patients with ST-elevation myocardial infarction in Peru].
Objectives: To determine one-year survival and factors associated with mortality in patients with ST-segment elevation myocardial infarction in Peru.
Methods: An analysis was made of the cohort of patients included in the PERSTEMI-II registry during the year 2020, in whom survival at one year after the event and its risk factors were evaluated using Kaplan-Meier survival analysis and Cox regression.
Results: Of 374 patients in the PERSTEMI-II study, 366 (97.9%) completed follow-up up to one year after the event with a survival rate of 85%. Successful reperfusion was related to better survival at 1 year (hazard ratio [HR]=0.30, 95% CI: 0.14-0.62, p=0.001). Age (HR=1.04, 95% CI: 1.01-1.07, p=0.003), chronic kidney disease (HR=2.15, 95% CI: 1.04-4.39, p=0.037) and cardiogenic shock (HR=6.67, 95% CI: 3.72-11.97, p<0.001) were factors of higher mortality at 1-year follow-up.
Conclusion: The PERSTEMI-II registry is the first Peruvian registry that provides data on survival after ST-segment elevation myocardial infarction, which is 85% at one year. Successful reperfusion improves survival at one-year post infarction.